Literature DB >> 12654772

On the use of DNA vaccines for the prophylaxis of mycobacterial diseases.

Kris Huygen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12654772      PMCID： PMC152041          DOI： 10.1128/IAI.71.4.1613-1621.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


× No keyword cloud information.
  78 in total

1.  Mixed immune response induced in rodents by two naked DNA genes coding for mycobacterial glycosylated proteins.

Authors:  A Garapin; L Ma; P Pescher; M Lagranderie; G Marchal
Journal:  Vaccine       Date:  2001-04-06       Impact factor: 3.641

2.  Genetic immunization is a simple method for eliciting an immune response.

Authors:  D C Tang; M DeVit; S A Johnston
Journal:  Nature       Date:  1992-03-12       Impact factor: 49.962

3.  Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle.

Authors:  J A Wolff; J J Ludtke; G Acsadi; P Williams; A Jani
Journal:  Hum Mol Genet       Date:  1992-09       Impact factor: 6.150

4.  Immunogenicity of DNA vaccines expressing tuberculosis proteins fused to tissue plasminogen activator signal sequences.

Authors:  Z Li; A Howard; C Kelley; G Delogu; F Collins; S Morris
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

5.  Characteristics and specificity of acquired immunologic memory to Mycobacterium tuberculosis infection.

Authors:  I M Orme
Journal:  J Immunol       Date:  1988-05-15       Impact factor: 5.422

6.  Direct gene transfer into mouse muscle in vivo.

Authors:  J A Wolff; R W Malone; P Williams; W Chong; G Acsadi; A Jani; P L Felgner
Journal:  Science       Date:  1990-03-23       Impact factor: 47.728

7.  Identification of major epitopes of Mycobacterium tuberculosis AG85B that are recognized by HLA-A*0201-restricted CD8+ T cells in HLA-transgenic mice and humans.

Authors:  A Geluk; K E van Meijgaarden; K L Franken; J W Drijfhout; S D'Souza; A Necker; K Huygen; T H Ottenhoff
Journal:  J Immunol       Date:  2000-12-01       Impact factor: 5.422

8.  Heterologous protection against influenza by injection of DNA encoding a viral protein.

Authors:  J B Ulmer; J J Donnelly; S E Parker; G H Rhodes; P L Felgner; V J Dwarki; S H Gromkowski; R R Deck; C M DeWitt; A Friedman
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

9.  Pulmonary necrosis resulting from DNA vaccination against tuberculosis.

Authors:  Jennifer L Taylor; Oliver C Turner; Randall J Basaraba; John T Belisle; Kris Huygen; Ian M Orme
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

10.  Assessment of immunity to mycobacterial infection with luciferase reporter constructs.

Authors:  V A Snewin; M P Gares; P O Gaora; Z Hasan; I N Brown; D B Young
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441
View more
  14 in total

1.  Magnetic resonance imaging of pulmonary lesions in guinea pigs infected with Mycobacterium tuberculosis.

Authors:  Susan L Kraft; Deanna Dailey; Matthew Kovach; Karen L Stasiak; Jamie Bennett; Christine T McFarland; David N McMurray; Angelo A Izzo; Ian M Orme; Randall J Basaraba
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

2.  Vaccine strategies against cystic fibrosis pathogens.

Authors:  Vincent Le Moigne; Jean-Louis Gaillard; Jean-Louis Herrmann
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

3.  Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection.

Authors:  Teresa M Wozniak; Anthony A Ryan; James A Triccas; Warwick J Britton
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

4.  Tuberculosis vaccines: current progress.

Authors:  Ian M Orme
Journal:  Drugs       Date:  2005       Impact factor: 9.546

5.  Expression levels of Mycobacterium tuberculosis antigen-encoding genes versus production levels of antigen-specific T cells during stationary level lung infection in mice.

Authors:  Brian J Rogerson; Yu-Jin Jung; Ronald LaCourse; Lynn Ryan; Nicholas Enright; Robert J North
Journal:  Immunology       Date:  2006-06       Impact factor: 7.397

6.  Expression library immunization confers protection against Mycobacterium avium subsp. paratuberculosis infection.

Authors:  J F Huntley; J R Stabel; M L Paustian; T A Reinhardt; J P Bannantine
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

7.  Immunogenicity and protective efficacy of tuberculosis DNA vaccines combining mycolyl-transferase Ag85A and phosphate transport receptor PstS-3.

Authors:  Marta Romano; Virginie Roupie; Xiao M Wang; Olivier Denis; Fabienne Jurion; Pierre-Yves Adnet; Rachid Laali; Kris Huygen
Journal:  Immunology       Date:  2006-07       Impact factor: 7.397

8.  Construction of a Novel DNA Vaccine Candidate Encoding an HspX-PPE44-EsxV Fusion Antigen of Mycobacterium tuberculosis.

Authors:  Bagher Moradi; Mojtaba Sankian; Yousef Amini; Zahra Meshkat
Journal:  Rep Biochem Mol Biol       Date:  2016-04

9.  RNA encoding the MPT83 antigen induces protective immune responses against Mycobacterium tuberculosis infection.

Authors:  Tian Xue; Evangelos Stavropoulos; Min Yang; Silvia Ragno; Martin Vordermeier; Mark Chambers; Glyn Hewinson; Douglas B Lowrie; M Joseph Colston; Ricardo E Tascon
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

10.  Mycobacterium bovis BCG vaccination as prophylaxis against Mycobacterium ulcerans osteomyelitis in Buruli ulcer disease.

Authors:  F Portaels; J Aguiar; M Debacker; A Guédénon; C Steunou; C Zinsou; W M Meyers
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.